News by Industry

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 1 of 3

UPS Agrees to Terms with ORTIE to Acquire Polish Healthcare Logistics Company Poltraf
12/18/2014 9:40:24 AM
UPS® (NYSE: UPS) today announced it has agreed to terms with Poland-based investment fund ORTIE to acquire its pharmaceutical logistics company Poltraf Sp. z o.o. The acquisition will further strengthen UPS’s healthcare expertise and network in Europe, enabling compliant logistics services to customers for streamlining their product supply to the fast-growing healthcare …
Garcinia Cambogia: Perhaps The Best Diet Pills For Women
Garcinia Cambogia: Perhaps The Best Diet Pills For Women
12/18/2014 9:28:26 AM
These days, there are a lot of discussions regarding Garcinia Cambogia as the best diet pills for women. However this product cannot be found in any local store, so where to buy it? When shoppers are purchasing any organic product, they have to ensure they are getting the right one that is obviously organic and not packed with fillers. Moreover, they have to ensure that …
Pioneering Prosthetic Treatments Help Amputees Get Their Lives Back On Track
Pioneering Prosthetic Treatments Help Amputees Get Their Lives Back On Track
12/18/2014 5:04:42 AM
Within the past few years many fantastic developments in prosthetics have been made. From 3D printing and skeletal infused implants to responsive mechanical prosthetics, the medical advances have been ground breaking, providing victims of amputation and those born without limbs a new alternative, greater comfort and increased mobility. Freeclaim Solicitors look at 3 of the …
Toshiba Opens Healthcare Technology Center and Enhances its Research and Development System in the Healthcare Business
Toshiba Opens Healthcare Technology Center and Enhances its Research and Development System in the Healthcare Business
12/17/2014 7:47:32 PM
Toshiba Corporation (Tokyo: 6502) today announced that it has opened the Healthcare Technology Center in the Komukai Complex in Kawasaki city, Kanagawa prefecture today. The center is established for the purpose of expanding the healthcare business under the medium-term management plan, and will serve as a base for the development of next-generation products as well as …
Teen prescription opioid abuse, cigarette, and alcohol use trends down
12/16/2014 10:21:01 AM
Use of cigarettes, alcohol, and abuse of prescription pain relievers among teens has declined since 2013 while marijuana use rates were stable, according to the 2014 Monitoring the Future (MTF) survey, released today by the National Institute on Drug Abuse (NIDA). However, use of e-cigarettes, measured in the report for the first time, is high. These 2014 results are part of …
FDA allows marketing of the first newborn screening test to help detect Severe Combined Immunodeficiency
12/16/2014 9:52:43 AM
The U.S. Food and Drug Administration today allowed marketing of the EnLite Neonatal TREC Kit, the first screening test permitted to be marketed by FDA for Severe Combined Immunodeficiency (SCID) in newborns. According to the Centers for Disease Control and Prevention, approximately 40 to100 new cases of SCID are identified in newborns in the United States each year. SCID …
The Newborn Screening Saves Lives Reauthorization Act of 2014
12/15/2014 1:13:05 PM
This past week, national newborn screening legislation unanimously passed the U.S. House of Representatives, and is now headed to President Barack Obama’s desk for signature. The bill implements new tracking measures and timetables aimed at eliminating critical delays in the newborn screening process, so that infants with deadly yet treatable genetic disorders can be diagnosed …
Durable, Colorable, Silky TPSiV® Elastomers from Dow Corning Show Favorable Results when Tested for Prolonged Skin Contact.
12/15/2014 9:03:28 AM
Dow Corning, a global leader in silicones, silicon-based technology and innovation, announced today that its TPSiV ® 4000 and TPSiV ® 4200 Thermoplastic Elastomers (TPEs) have been tested according to United States Pharmacopeia’s (USP) General Chapter -88- and ISO 10993-10 guidelines and have shown to be non irritating and non sensitizing in skin contact applications. The …
Youngest bone marrow transplant patients at higher risk of cognitive decline
12/11/2014 3:40:30 PM
Toddlers who undergo total body irradiation in preparation for bone marrow transplantation are at higher risk for a decline in IQ and may be candidates for stepped up interventions to preserve intellectual functioning, St. Jude Children’s Research Hospital investigators reported. The findings appear in the current issue of the Journal of Clinical Oncology . The results …
Dr. David Perna Featured on The Dr. Oz Show
Dr. David Perna Featured on The Dr. Oz Show
12/10/2014 8:00:00 AM
New York, NY: On Wednesday, November 12, 2014, David Perna DC, CCSP, CCEP of Back and Body Medical was featured on the Dr. Oz show to demonstrate his expertise in the treatment of muscle and joint pain, specifically Ultrasound Therapy. As a practitioner renowned for his knowledge in chiropractic care and physio therapy, Dr. Perna was featured in a segment with Natalie …
Sobi CEO Geoffrey McDonough sells a portion of 2014 incentive shares
12/9/2014 8:53:22 AM
During the first week of December 2014 Sobi’s CEO Geoffrey McDonough sold 350,000 of the shares he holds in Sobi. The sale was made in order to cover the estimated US tax liability for both the company’s CEO incentive share programme, which vested in September 2014, and for the vesting in mid-December 2014 of the company’s 2011 long-term incentive programme. This is the first …
Smoking Still Causes Large Proportion of Cancer Deaths in the United States
12/9/2014 8:43:29 AM
A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer …
Birmingham to lead pioneering study to test new treatment for Sjogren’s syndrome
12/8/2014 11:57:20 AM
The National Institute for Health Research (NIHR) has today announced the start of the UK’s first commercial trial of a new treatment for Sjogren’s syndrome. Up to half a million people in the UK are affected by the autoimmune condition. The study will test a new antibody treatment, which has the potential to bring relief to sufferers with Sjogren’s syndrome, a condition …
Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark
12/8/2014 11:53:25 AM
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas® HIV-1 and cobas HCV assays for use on the cobas 6800/8800 Systems—expanding the menu on the newest molecular diagnostic platforms from Roche with next generation viral load monitoring assays. The new assays offer the high performance that clinicians depend on to manage the treatment …
Older Breast Cancer Patients Still Get Radiation Despite Limited Benefit
12/8/2014 8:47:17 AM
Women over the age of 70 who have certain early-stage breast cancers overwhelmingly receive radiation therapy despite published evidence that the treatment has limited benefit, researchers at Duke Medicine report. The study suggests that doctors and patients may find it difficult to withhold treatment previously considered standard of care, even in the setting of high …
Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients
12/8/2014 8:34:19 AM
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD , a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today at the 56th Annual Meeting of the American Society of Hematology. Approximately 15 percent of …
Basilea announces launch of antibiotic Zevtera® (ceftobiprole medocaril) in Germany
12/5/2014 1:02:56 PM
Basilea Pharmaceutica Ltd. (SIX: BSLN) announces today that its broad-spectrum antibiotic, Zevtera® (ceftobiprole medocaril)* has been launched in Germany. The European Centre for Disease Prevention and Control (ECDC) estimates that every year approximately 25,000 people die from antibiotic-resistant healthcare-associated infections in the European Union.1 The new …
American Association for Cancer Research Recognizes Dr. Mary-Claire King With 2014 Distinguished Lectureship in Breast Cancer Research
12/5/2014 12:26:05 PM
Mary-Claire King, PhD, the American Cancer Society professor in the Departments of Medicine (Medical Genetics) and Genome Sciences at the University of Washington School of Medicine in Seattle, is being honored with the Seventh Annual American Association for Cancer Research (AACR) Distinguished Lectureship in Breast Cancer Research, at the 2014 San Antonio Breast Cancer …
Brain Activity after Smokers Quit Predicts Chances of Relapsing, Penn Medicine Study Suggests
12/3/2014 12:03:53 PM
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk. Reporting in a new study published this week in the journal Neuropsychopharmacology , James Loughead, PhD , associate …
Three Easy Tips to Help Treat Baby Rash and Eczema in Babies
12/2/2014 9:55:11 PM
QUEENSLAND, Australia December 2014 – Newborn skin is soft, sensitive and delicate, and an infant’s immune system is fragile. While adults can absorb up to 60 per cent of what is rubbed on the skin in to their bodies, children take in 40 to 50 per cent more than adults. As most baby care products contain parabens, dioxane, formaldehyde and many other harmful chemicals, baby …